Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas

City of Hope Medical Center · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
cd30-positive neoplastic cells present, folliculotropic mycosis fungoides, recurrent mycosis fungoides, recurrent primary cutaneous t-cell non-hodgkin lymphoma, refractory mycosis fungoides, refractory primary cutaneous t-cell non-hodgkin lymphoma, sezary syndrome, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 857285
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.